<DOC>
	<DOCNO>NCT01816022</DOCNO>
	<brief_summary>This clinical study evaluate effect CMPN ( Chronic myeloproliferative neoplasm ) bone . The hypothesis patient CMPN high fracture-rate compare background population . We expect find low BMD use conventional DXA scan ( dual energy x-ray absorptiometry ) , change parameter use HR-pQCT ( high-resolution peripheral quantitative computerize tomography ) .Biochemical bone marker measure support hypothesis .</brief_summary>
	<brief_title>Myeloproliferative Neoplasms Bone Structure</brief_title>
	<detailed_description>This clinical study evaluate effect CMPN bone . Three individual cohort define ; cohort consist 50 patient Polycythemia Vera ( PV ) , cohort consist 50 patient Essential Thrombocythemia ( ET ) , cohort consist 25 patient Primary Myelofibrosis ( PMF ) . Patients recruit Department Hematology , Odense University Hospital . Interventions consist : - Conventional DXA scan measure Bone Mineral Density ( BMD ) . - Experimental HR-pQCT ass geometry , strength microstructure bone 3 dimension . - Blood-samples collect frozen later analyse Biochemical Bone Markers : 1-CTP , Ctx , ALP ( alkaline phosphatase ) P1NP . The outcome compare healthy control individual .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Primary Myelofibrosis</mesh_term>
	<mesh_term>Polycythemia</mesh_term>
	<mesh_term>Polycythemia Vera</mesh_term>
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<mesh_term>Thrombocytosis</mesh_term>
	<mesh_term>Thrombocythemia , Essential</mesh_term>
	<criteria>Diagnosis PV ( accord WHO 2008 criterion ) , JAK2pos . ( Janus kinase 2 ) Diagnosis ET ( accord WHO 2008 criterion ) , JAK2pos . Diagnosis PMF ( accord WHO 2008 criterion ) independent JAK2status . Pregnancy Bone Diseases ( Mb . Pagets , Myelomatosis , MGUS ( monoclonal gammopathy undetermined significance ) , osteogenesis imperfecta , Prim . hyperparathyroidism , osteomalacia . Drugs ( Prednisone &gt; 3 mth , antiosteoporotic drug , antiestrogen drug . Presence psychologic condition language barrier , may interfere complete understanding , arise ethnical consideration .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>CMPN</keyword>
	<keyword>Fracture</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Biochemical Bone Markers</keyword>
</DOC>